TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-03
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionStrs Ohio
Latest Disclosed Ownership8,700 shares
Latest Disclosed Value $ 289,014
Strs Ohio ownership in 1TGTX / TG Therapeutics, Inc.

On April 24, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 8,700 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $240,642 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 8,700 shares of TG Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $295,800 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F TG THERAPEUTICS COM_STK 88322Q108 8,700 0 0.00 289 11.58 0.0011
2026-02-02 2025-12-31 13F TG THERAPEUTICS COM_STK 88322Q108 8,700 -6,800 -43.87 259 -53.67 0.0010
2025-10-30 2025-09-30 13F TG THERAPEUTICS COM_STK 88322Q108 15,500 -8,900 -36.48 560 -36.33 0.0021
2025-08-04 2025-06-30 13F TG THERAPEUTICS COM_STK 88322Q108 24,400 4,500 22.61 878 11.99 0.0033
2025-05-28 2025-03-31 13F TG THERAPEUTICS COM_STK 88322Q108 19,900 -4,100 -17.08 785 8.59 0.0033
2025-05-28 2024-12-31 13F TG THERAPEUTICS COM_STK 88322Q108 24,000 -11,400 -32.20 722 -12.80 0.0029
2024-11-01 2024-09-30 13F TG THERAPEUTICS COM_STK 88322Q108 35,400 -2,600 -6.84 828 22.49 0.0032
2024-08-05 2024-06-30 13F TG THERAPEUTICS COM_STK 88322Q108 38,000 29,100 326.97 676 0.0027
2024-05-13 2024-03-31 13F TG THERAPEUTICS COM_STK 88322Q108 8,900 -8,600 -49.14 0 0.0005
2024-01-30 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 17,500 17,500 0 0.0012
2023-10-26 2023-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 0 -8,000 -100.00 0 0.0000
2023-10-26 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 0 0
2023-07-31 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 8,000 8,000 0 0.0008
2022-10-27 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 0 -26,900 -100.00 0 -100.00
2022-07-25 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 26,900 4,800 21.72 114 -45.71 0.0005
2022-04-21 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 22,100 0 0.00 210 -49.88 0.0008
2022-01-24 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 22,100 -1,000 -4.33 419 -45.44 0.0015
2021-10-22 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 23,100 -3,100 -11.83 768 -24.41 0.0029
2021-07-26 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 26,200 -7,300 -21.79 1,016 -37.05 0.0037
2021-04-23 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 33,500 11,300 50.90 1,614 39.86 0.0061
2021-01-25 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 22,200 6,600 42.31 1,154 176.74 0.0045
2020-12-14 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 15,600 10,900 231.91 417 358.24 0.0017
2020-07-23 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 4,700 4,700 91 0.0004
2015-01-23 2014-12-31 13F TG THERAPEUTICS COM 88322Q108 0 -11,400 -100.00 0 -100.00
2014-10-29 2014-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 11,400 6,100 115.09 122 144.00 0.0005
2014-10-20 2014-09-30 13F TG THERAPEUTICS COM 88322Q108 11,400 122
2014-07-24 2014-06-30 13F TG THERAPEUTICS COM 88322Q108 5,300 0 0.00 50 35.14 0.0002
2014-04-28 2014-03-31 13F TG THERAPEUTICS COM 88322Q108 5,300 0 0.00 37 76.19 0.0002
2014-01-30 2013-12-31 13F TG THERAPEUTICS COM 88322Q108 5,300 -600 -10.17 21 -30.00 0.0001
2013-10-24 2013-09-30 13F TG THERAPEUTICS COM 88322Q108 5,900 0 0.00 30 -21.05 0.0001
2013-08-12 2013-06-30 13F TG THERAPEUTICS COM 88322Q108 5,900 5,900 38 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.